Patents by Inventor Hans-Konrad Mueller-Hermelink

Hans-Konrad Mueller-Hermelink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adenocarcinoma specific antibody SAM-6, and uses thereof
    Patent number: 8741296
    Abstract: The present invention features a polypeptide, such as an antibody produced by the hybridoma SAM-6 and its use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: June 3, 2014
    Assignee: Patrys Limited
    Inventors: Heinz Peter Vollmers, Hans-Konrad Müller-Hermelink
  • Neoplasm specific antibodies and uses thereof
    Patent number: 8562995
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: May 19, 2011
    Date of Patent: October 22, 2013
    Assignee: Patrys Limited
    Inventors: Hans-Konrad Müeller-Hermelink, Heinz Peter Vollmers
  • ADENOCARCINOMA SPECIFIC ANTIBODY SAM-6, AND USES THEREOF
    Publication number: 20130039849
    Abstract: The present invention features a polypeptide, such as an antibody produced by the hybridoma SAM-6 and its use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: March 23, 2012
    Publication date: February 14, 2013
    Applicant: PATRYS LIMITED
    Inventors: HEINZ VOLLMERS, Hans-Konrad Müller-Hermelink
  • Adenocarcinoma specific antibody SAM-6, and uses thereof
    Patent number: 8163552
    Abstract: A purified polypeptide that binds to neoplastic cells, which may be an antibody, is produced by the hybridoma SAM-6, a method for its production and use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: April 24, 2012
    Assignee: Patrys Limited
    Inventors: Heinz Vollmers, Hans-Konrad Müller-Hermelink
  • NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20110287021
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: May 19, 2011
    Publication date: November 24, 2011
    Applicant: PATRYS LIMITED
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Peter Vollmers
  • Neoplasm specific antibodies and uses thereof
    Patent number: 7947812
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: March 15, 2004
    Date of Patent: May 24, 2011
    Assignee: Patrys Limited
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Peter Vollmers
  • NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20110076763
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: August 17, 2010
    Publication date: March 31, 2011
    Applicant: PATRYS LIMITED
    Inventors: HEINZ PETER VOLLMERS, Hans Konrad Mueller-Hermelink
  • SUBSTANCE FOR OBTAINING HIGHLY EFFECTIVE TUMOR MEDICATIONS AS WELL AS A PROCESS
    Publication number: 20110027182
    Abstract: The invention relates to a substance and a process for obtaining anti-tumor agents.
    Type: Application
    Filed: July 1, 2010
    Publication date: February 3, 2011
    Inventors: Heinz-Peter Vollmers, Hans Konrad Mueller-Hermelink, Annette Buechner-Vollmers
  • ANTI-IDIOTYPE ANTIBODIES OF THE HUMAN MONOCLONAL ANTIBODY SC-1, AND THEIR PRODUCTION AND USE
    Publication number: 20100316630
    Abstract: The invention features anti-idiotype antibodies of the human monoclonal antibody SC-1, as well as methods for producing and using the anti-idiotype antibodies.
    Type: Application
    Filed: November 3, 2009
    Publication date: December 16, 2010
    Inventors: HEINZ PETER VOLLMERS, HANS KONRAD MÜLLER-HERMELINK
  • NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20100317826
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: June 7, 2010
    Publication date: December 16, 2010
    Applicant: PATRYS LIMITED
    Inventors: HANS-KONRAD MUELLER-HERMELINK, Heinz Vollmers
  • Neoplasm specific antibodies and uses thereof
    Patent number: 7772372
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: August 10, 2010
    Assignee: Patrys Limited
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Vollmers
  • Substance for obtaining highly effective tumor medications as well as a process
    Patent number: 7767787
    Abstract: The invention relates to a substance and a process for obtaining anti-tumor agents.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: August 3, 2010
    Assignee: Debiovision Inc.
    Inventors: Heinz Peter Vollmers, Hans Konrad Mueller-Hermelink
  • Neoplasm specific antibodies and uses thereof
    Patent number: 7741444
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: June 22, 2010
    Assignee: Patrys Limited
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Peter Vollmers
  • Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and use
    Patent number: 7611894
    Abstract: The invention features anti-idiotype antibodies of the human monoclonal antibody SC-1, as well as methods for producing and using the anti-idiotype antibodies.
    Type: Grant
    Filed: November 15, 2004
    Date of Patent: November 3, 2009
    Assignee: Debiovision
    Inventors: Heinz Peter Vollmers, Hans Konrad Müller-Hermelink
  • PM-2 ANTIBODIES, FUNCTIONAL FRAGMENTS AND METHODS FOR TREATING METASTASIS
    Publication number: 20090202570
    Abstract: The invention provides PM-2 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a PM-2 antibody or functional fragment thereof effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Application
    Filed: December 19, 2008
    Publication date: August 13, 2009
    Applicant: PATRYS LIMITED
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Vollmers, Bertram Illert
  • Neoplasm-specific polypeptides and their uses
    Patent number: 7378247
    Abstract: The present invention features novel polypeptides and methods of using these polypeptides in the diagnosis, detection, monitoring, and treatment of neoplasms in a mammal, e.g., a human.
    Type: Grant
    Filed: January 26, 2004
    Date of Patent: May 27, 2008
    Assignee: Debiovision Inc.
    Inventors: Hans Konrad Müller-Hermelink, Heinz Peter Vollmers, Frank Hensel
  • NEOPLASM SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20080020457
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: August 14, 2007
    Publication date: January 24, 2008
    Applicant: PATRYS LIMITED
    Inventors: HANS-KONRAD MUELLER-HERMELINK, Heinz Vollmers
  • Neoplasm specific antibodies and uses thereof
    Publication number: 20060263366
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: March 15, 2004
    Publication date: November 23, 2006
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Vollmers
  • Neoplasm specific antibodies and uses thereof
    Publication number: 20060074229
    Abstract: The present invention features polypeptides, such as antibodies, and their use in the treatment and diagnosis of neoplasms.
    Type: Application
    Filed: July 2, 2003
    Publication date: April 6, 2006
    Inventors: Hans-Konrad Mueller-Hermelink, Heinz Vollmers